Company profile: Cellzome
1.1 - Company Overview
Company description
- Provider of kinase-targeted drugs and oral kinase inhibitor therapeutics for inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma; engaged in discovery, development, and commercialization.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellzome
Brooks Running
HQ: United States
Website
- Description: Provider of automation, vacuum, and instrumentation solutions for the worldwide semiconductor manufacturing industry, including wafer handling robotics and integrated tool automation systems, vacuum and atmospheric robots, configurable transfer and transport platforms (MagnaTran LEAP, Marathon LEAP AX, Marathon Express), and pathology lab automation (PathFinder Benchtop, Tube Decapper).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brooks Running company profile →
Caliper Life Sciences
HQ: United States
Website
- Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliper Life Sciences company profile →
Nanosphere
HQ: United States
Website
- Description: Provider of a nanotechnology-based molecular diagnostics platform and clinical tests for genomic and protein testing and analysis. Instruments use microfluidics to pull DNA and proteins, delivering results in hours rather than days or weeks, with sensitivity two to three times higher than common hospital lab tests and much simpler.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanosphere company profile →
PrimeraDx
HQ: United States
Website
- Description: Provider of multiplexed infectious disease assays and Scalable Target Amplification Routine technology for simultaneous quantitative measurement of multiple nucleic acid targets. Offers the ICEPlex system combining PCR and capillary electrophoresis, companion diagnostics, a C. difficile assay, ViraQuant for virus quantification, translational medicine research solutions, and pharma quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PrimeraDx company profile →
Magnolia Medical
HQ: United States
Website
- Description: Provider of blood culture contamination reduction solutions, including Steripath Initial Specimen Diversion Device and Steripath Micro to divert and sequester initial blood draws, the Mission Control educational platform offering best-practice collection training, and a clinical performance guarantee of at least 50% contamination reduction or money back.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnolia Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellzome
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellzome
2.2 - Growth funds investing in similar companies to Cellzome
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellzome
4.2 - Public trading comparable groups for Cellzome
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →